# CONVERGE CAP Study-For The Treatment Of Symptomatic Persistent or Long-standing Persistent AF

> **NCT04239534** · NA · WITHDRAWN · sponsor: **AtriCure, Inc.**

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DEVICE:** Convergence Of Epicardial And Endocardial RF Ablation

## Key facts

- **NCT ID:** NCT04239534
- **Lead sponsor:** AtriCure, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-12
- **Primary completion:** 2023-12
- **Final completion:** 2026-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Start-up and enrolling activities have been suspended and study closed
- **Last updated:** 2022-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04239534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04239534, "CONVERGE CAP Study-For The Treatment Of Symptomatic Persistent or Long-standing Persistent AF". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04239534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*